Literature DB >> 15032073

Clinical practice guidelines and performance indicators as related--but often misunderstood--tools.

Ann S O'Malley1, Carolyn Clancy, Joe Thompson, Ravikiran Korabathina, Gregg S Meyer.   

Abstract

BACKGROUND: Widespread variation in medical practice indicates that existing scientific evidence is often not translated into appropriate clinical care. Two tools have evolved that try to address this variation: clinical practice guidelines (CPGs) and performance indicators (PIs). TENSIONS BETWEEN CPGS AND PIS: CPGs present available evidence that is subsequently reviewed and frequently adopted by professional organizations, so that clinicians may judge whether specific management recommendations are appropriate for each patient. PIs are devised to measure and document performance to motivate organizations to improve through the use of common metrics. IMPLICATIONS OF THESE TENSIONS: The increasingly widespread use of PIs with CPGs (and clinicians' confusion of them with CPGs) risks lowering the standards of clinical care. PIs are not intended to set optimal standards of care for any individual patient. Clinicians should not restrict their quality monitoring to a focus on PIs because they could miss important opportunities to learn and to improve the care they deliver to their individual patients.
CONCLUSION: Tensions between CPGs and PIs do not mean that these tools should be abandoned but rather that they need to be refined. Recognition of the imperfections of CPGs and PIs should not blind clinicians to the ultimate goals of these tools--to promote quality (through changes in practice and/or selection) and ensure that medical care is based on scientific evidence.

Entities:  

Mesh:

Year:  2004        PMID: 15032073     DOI: 10.1016/s1549-3741(04)30018-3

Source DB:  PubMed          Journal:  Jt Comm J Qual Saf        ISSN: 1549-3741


  8 in total

1.  Predictors of the growing influence of clinical practice guidelines.

Authors:  Ann S O'malley; Hoangmai H Pham; James D Reschovsky
Journal:  J Gen Intern Med       Date:  2007-03-27       Impact factor: 5.128

2.  The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus.

Authors:  Sei J Lee; W John Boscardin; Irena Stijacic Cenzer; Elbert S Huang; Kathy Rice-Trumble; Catherine Eng
Journal:  J Am Geriatr Soc       Date:  2011-04-11       Impact factor: 5.562

3.  Population-based longitudinal study of follow-up care for patients with colorectal cancer in Nova Scotia.

Authors:  Robin Urquhart; Amy Folkes; Geoffrey Porter; Cynthia Kendell; Martha Cox; Ron Dewar; Eva Grunfeld
Journal:  J Oncol Pract       Date:  2012-07       Impact factor: 3.840

4.  Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida.

Authors:  Tawee Tanvetyanon; Michelle Corman; Ji-Hyun Lee; William J Fulp; Fred Schreiber; Richard H Brown; Richard M Levine; Thomas H Cartwright; Guillermo Abesada-Terk; George P Kim; Carlos Alemany; Douglas Faig; Philip V Sharp; Merry-Jennifer Markham; Gerold Bepler; Erin Siegel; David Shibata; Mokenge Malafa; Paul B Jacobsen
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

5.  Diabetes mellitus performance measures in individuals with limited life expectancy.

Authors:  Sei J Lee; Cynthia M Boyd
Journal:  J Am Geriatr Soc       Date:  2012-02       Impact factor: 5.562

6.  When tight blood pressure control is not for everyone: a new model for performance measurement in hypertension.

Authors:  Michael A Steinman; Mary K Goldstein
Journal:  Jt Comm J Qual Patient Saf       Date:  2010-04

Review 7.  Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review.

Authors:  Damin Si; Ross Bailie; Zhiqiang Wang; Tarun Weeramanthri
Journal:  BMC Health Serv Res       Date:  2010-06-17       Impact factor: 2.655

8.  Mitigating case mix factors by choice of glycemic control performance measure threshold.

Authors:  Kathleen E Bainbridge; Catherine C Cowie; Keith F Rust; Judith E Fradkin
Journal:  Diabetes Care       Date:  2008-05-28       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.